Patient Pathfinder: Clinical Trials
Clinical Trials for Bladder Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 279 active Bladder Cancer trials
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
Study Type: Interventional Phase 3
HER2 and LA/mUC: A Multi-country Chart Review Cohort Study
Study Type: Observational
Enhanced Recovery After Surgery (ERAS) for Ambulatory TURBT
Study Type: Interventional
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
Study Type: Interventional
Detection and Risk Stratification in Veterans Presenting With Microscopic Hematuria
Study Type: Observational
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
Study Type: Interventional Phase 1
Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer
Study Type: Interventional Phase 2
Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Study Type: Interventional Phase 1
There are 279 active Bladder Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now